Figure 2. Overall survival (OS) of all patients.
(A) OS of the whole cohort of CLL patients. (B) OS stratified according to the FISH abnormalities. (C) OS stratified according to the NOTCH1 mutations. (D) OS stratefied according to the IGHV mutation status.